Second Malignancies in Pediatric Patients: Imaging Findings and Differential Diagnosis

Radiographics

Volumn 23, Issue 5, 2003, Pages 1155-1172

  Vázquez, Elida ^a   Castellote, Amparo ^a   Piqueras, Joaquim ^a   Ortuño, Pedro ^a   Sánchez Toledo, José ^a   Nogués, Pere ^a   Lucaya, Javier ^a  

^a HOSPITAL MATERNO INFANTIL VALL D HEBRON   (Spain)

Author keywords

Chemotherapy, complications; Neoplasms, CT, **. 1211 2; Neoplasms, in infants and children, **. 32; Neoplasms, MR, **. 1214; Radiations, injurious effects, neoplastic, **. 47

Indexed keywords

CYCLOPHOSPHAMIDE; GYRASE INHIBITOR;

ACUTE MYELOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; BONE MARROW TRANSPLANTATION; CANCER RISK; CANCER SURVIVAL; CENTRAL NERVOUS SYSTEM TUMOR; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; FOLLOW UP; HUMAN; IMAGING SYSTEM; INFANT; IONIZATION; LYMPHOMA; MEDULLOBLASTOMA; NEUROBLASTOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; PAROTID GLAND CARCINOMA; PROGNOSIS; RADIATION INJURY; RETINOBLASTOMA; SARCOMA; SECOND CANCER; THYROID CARCINOMA; RADIOGRAPHY; REVIEW;

CHILD; DIAGNOSIS, DIFFERENTIAL; HUMANS; NEOPLASMS, SECOND PRIMARY;

EID: 0142029156     PISSN: 02715333     EISSN: None     Source Type: Journal    
DOI: 10.1148/rg.235035040     Document Type: Article

References (52)

1. Edwards-Brown MK, Jakacki RI. Imaging the CNS effects of radiation and chemotherapy of pediatric tumors. Neuroimag Clin North Am 1999; 9:177-193.
2. Dalton VMK, Gelber RD, Li F, Donnelly MJ, Tarbell NJ, Sallan SE. Second malignancies in patients treated for childhood acute lymphoblastic leukemia. J Clin Oncol 1998; 16:2848-2853.
3. Nishio S, Morioka T, Inamura T, et al. Radiation-induced brain tumors: potential late complications of radiation therapy for brain tumors. Acta Neurochir 1998; 140:763-770.
4. Moppett J, Oakhill A, Duncan AW. Second malignancies in children: the usual suspects? Eur J Radiol 2001; 37:235-248.
5. Kony SJ, de Vathaire F, Chompret A, et al. Radiation and genetic factors in the risk of second malignant neoplasms after a first cancer in childhood. Lancet 1997; 350:91-95.
6. Vazquez E, Lucaya J, Castellote A, et al. Neuroimaging in pediatric leukemia/lymphoma: differential diagnosis. RadioGraphics 2002; 22:1411-1428.
7. Parisi MT, Fahmy JL, Kaminsky CK, Malogolowkin MH. Complications of cancer therapy in children: a radiologist's guide. RadioGraphics 1999; 19:283-297.
8. Chen CY, Zimmerman RA, Faro S, Bilaniuk LT, Chou TY, Molloy PT. Childhood leukemia: CNS abnormalities during and after treatment. AJNR Am J Neuroradiol 1996; 17:295-310.
9. Ball WS Jr, Prenger EC, Ballard ET. Neurotoxicity of radio/chemotherapy in children: pathologic and MR evaluation. AJNR Am J Neuroradiol 1992; 13:761-776.
10. Barkovich AJ. Pediatric neuroimaging. 3rd ed. Philadelphia, Pa: Lippincott Williams & Wilkins, 2000.
11. Ghim TT, Seo JJ, O'Brien M, Meacham L, Crocker I, Krawiecki N. Childhood intracranial meningioma after high-dose irradiation. Cancer 1993; 71:4091-4095.
12. Chang SM, Barker FG II, Laarson DA, Bollen AW, Prados MD. Sarcomas subsequent to cranial irradiation. Neurosurgery 1995; 36:685-690.
13. Dodick DW, Mokri B, Shaew EG, Miller GM, Unni KK. Sarcomas of the calvarial bones: rare remote effect of radiation therapy for brain tumors. Neurology 1994; 44:908-912.
14. Brachman DG, Hallahn DE, Beckett MA, Yandell DW, Weichselbaum RR. p55 gene mutations and abnormal retinoblastoma protein in radiation-induced human sarcomas. Cancer Res 1991; 51: 6393-6396.
15. Tada M, Sawamura Y, Abe H, Iggo R. Homozygous p53 gene mutation in a radiation-induced glioblastoma 10 years after treatment for an intracranial germ cell tumor: case report. Neurosurgery 1997; 40:393-396.
16. Goldstein AM, Yuen J, Tucker MA. Second cancers after medulloblastoma: population-based results from the United States and Sweden. Cancer Causes Control 1997; 8:865-871.
17. Neglia JP, Meadows AT, Robinson LL, et al. Second neoplasms after acute lymphoblastic leukemia in childhood. N Engl J Med 1991; 325:1330-1336.
18. Pui CH, Relling MV. Topoisomerase II inhibitor-related acute myeloid leukaemia. Br J Haematol 2000; 109:13-23.
19. Socie G, Curtis RE, Deeg HJ, et al. New malignant diseases after allogeneic marrow transplantation for childhood acute leukemia. J Clin Oncol 2000; 18:348-357.
20. Baria K, Warren C, Eden OB, Roberts SA, West CM, Scott D. Chromosomal radiosensitivity in young cancer patients: possible evidence of genetic predisposition. Int J Radiat Biol 2002; 78:341-346.
21. Li FP, Fraumeni JF, Mulhivill JJ, et al. A cancer family syndrome in twenty-four kindreds. Cancer Res 1988; 48:5358-5362.
22. Little MP, de Vathaire F, Shamsaldin A, et al. Risks of brain tumour following treatment for cancer in childhood: modification by genetic factors, radiotherapy and chemotherapy. Int J Cancer 1998; 78:269-275.
23. Hampel H, Peltomaki P. Hereditary colorectal cancer: risk assessment and management. Clin Genet 2000; 58:89-97.
24. Triki C, Feki I, Meziou M, Turki H, Zahaf A, Mhiri C. Clinical, biological and genetic study of 24 patients with ataxia telangiectasia from southern Tunisia. Rev Neurol 2000; 156:634-637.
25. Taylor AM, Metcalfe JA, Thick J, Mak YF. Leukemia and lymphoma in ataxia telangiectasia. Blood 1996; 87:423-438.
26. van Heurn LW, Schaap C, Sie G, et al. Predictive DNA testing for multiple endocrine neoplasia 2: a therapeutic challenge of prophylactic thyroidectomy in very young children. J Pediatr Surg 1999; 34:568-571.
27. Lynch TM, Gutmann DH. Neurofibromatosis 1. Neurol Clin 2002; 20:841-865.
28. Chan LL, Czerniak BA, Ginsberg LE. Radiation-induced osteosarcoma after bilateral childhood retinoblastoma. AJR Am J Roentgenol 2000; 174: 1288.
29. Coppes MJ, Egeler RM. Genetics of Wilms' tumor. Semin Urol Oncol 1999; 17:2-10.
30. Egeler RM, Wolff JE, Anderson RA. Long-term complications and post-treatment follow-up of patients with Wilms' tumor. Semin Urol Oncol 1999; 17:55-61.
31. Walter AW, Hancock ML, Pui CH, Hudson MM, et al. Secondary brain tumors in children treated for acute lymphoblastic leukemia at St Jude Children's Research Hospital. J Clin Oncol 1998; 16: 3761-3767.
32. Foreman NK, Laitt RD, Chambers EJ, Duncan AW, Cummins BH. Intracranial large vessel vasculopathy and anaplastic meningioma 19 years after cranial irradiation for acute lymphoblastic leukemia. Med Pediatr Oncol 1995; 24:265-268.
33. Choi D, Seex K. Intracranial meningioma following childhood irradiation for leukaemia. Br J Hematol 2000; 108:665.
34. Musa BS, Pople IK, Cummins BH. Intracranial meningiomas following irradiation: a growing problem? Br J Neurosurg 1995; 9:629-637.
35. Dorfmuller G, Wurtz FG, Kleinert R, Lanner G. Cerebral primitive neuroectodermal tumour following treatment of a unilateral retinoblastoma. Acta Neurochir (Wien) 1997; 139:749-755.
36. Wong FL, Boice JD, Abramson DH, et al. Cancer incidence after retinoblastoma: radiation dose and sarcoma risk. JAMA 1997; 278:1262-1267.
37. Maes P, Brichard B, Vermylen C, Cornu G, Ninane J. Primary and secondary osteosarcoma of the face: a rare childhood malignancy. Med Pediatr Oncol 1998; 30:170-174.
38. Kaste SC, Hedlund G, Pratt CB. Malignant parotid tumors in patients previously treated for childhood cancer: clinical and imaging findings in eight cases. AJR Am J Roentgenol 1994; 162:655-659.
39. Crom DB, Kaste SC, Tubergen DG, Greenwald CA, Sharp GB, Hudson MM. Ultrasonography for thyroid screening after head and neck irradiation in childhood cancer survivors. Med Pediatr Oncol 1997; 28:15-21.
40. Farahati J, Demidchik, EP, Biko J, Reiners C. Inverse association between age at time of radiation exposure and extent of disease in cases of radiation-induced childhood thyroid carcinoma in Belarus. Cancer 2000; 88:1470-1476.
41. Nagataki S, Nystrom E. Epidemiology and primary prevention of thyroid cancer. Thyroid 2002; 12:889-896.
42. Black P, Straaten A, Gutjahr P. Secondary thyroid carcinoma after treatment for childhood cancer. Med Pediatr Oncol 1998; 31:91-95.
43. de Vathaire F, Hardiman C, Shamsaldin A, et al. Thyroid carcinomas after irradiation for a first cancer during childhood. Arch Intern Med 1999; 159:2713-2719.
44. Swerdlow AJ, Barber JA, Hudson GV, et al. Risk of second malignancy after Hodgkin's disease in a collaborative British cohort: the relation to age at treatment. J Clin Oncol 2000; 18:498-509.
45. Sandler ES, Friedman DJ, Mustafa MM, Winick NJ, Bowman WP, Buchanan GR. Treatment of children with epipodophyllotoxin-induced secondary acute myeloid leukemia. Cancer 1997; 79: 1049-1054.
46. Farhi DC, Odell CA, Shurin SB. Myelodysplastic syndrome and acute myeloid leukemia after treatment for solid tumors of childhood. Am J Clin Pathol 1993; 100:270-275.
47. Valk PE, Dillon WP. Radiation injury of the brain. AJNR Am J Neuroradiol 1991; 12:45-62.
48. Rabinov JD, Lee PL, Barker FG, et al. In vivo 3-T MR spectroscopy in the distinction of recurrent glioma versus radiation effects: initial experience. Radiology 2002; 225:871-879.
49. Kimura T, Sako K, Gotoh T, Tanaka K, Tanaka T. In vivo single-voxel proton MR spectroscopy in brain lesions with ring-like enhancement. NMR Biomed 2001; 14:339-349.
50. Sugahara T, Korogi Y, Tomiguchi S, et al. Post-therapeutic intraaxial brain tumor: the value of perfusion-sensitive contrast-enhanced MR imaging for differentiating tumor recurrence from non-neoplastic contrast-enhancing tissue. AJNR Am J Neuroradiol 2000; 21:901-909.
51. Plowman PN, Saunders CA, Maisey M. On the usefulness of brain PET scanning to the paediatric neuro-oncologist. Br J Neurosurg 1997; 11:525-532.
52. Chao ST, Suh JH, Raja S, Lee SY, Barnett G. The sensitivity and specificity of FDG PET in distinguishing recurrent brain tumor from radionecrosis in patients treated with stereotactic radiosurgery. Int J Cancer 2001; 96:191-197.